ArticleJournal of medical physics
A Comprehensive Dosimetric Evaluation and Performance Validation of the Newly Introduced HyperSight™ Cone-beam Computed Tomography System in India - Is It Now Feasible to Eliminate the Intermediate Step in Adaptive Radiotherapy Planning?: A Phantom Study.
Article in Journal of medical physics. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Cone-beam computed tomography (CBCT) is integral to modern adaptive radiotherapy (ART) but is often limited by a small field of view, longer acquisition times, and inferior image quality compared with planning CT. Consequently, ART plan optimization and calculations are typically performed using synthetic CT. HyperSight™ is a recent technological advancement that addresses these limitations through a large-area detector, faster gantry rotation, and improved image quality. This system has been recently introduced in India, and this first Indian study represents the comprehensive, quality assurance (QA)-focused evaluation. In the second phase, its suitability for direct dose optimization and calculation was assessed using standard phantoms. Materials and Methods: The study was conducted on a Halcyon equipped with the HyperSight™ CBCT platform. Fan-beam scans were acquired using both big-bore and conventional CT systems. Standard QA tools, along with QUART and Catphan phantoms, were employed. X-ray tube performance tests, Image quality tests, Hounsfield units (HU) accuracy and constancy tests etc., were evaluated in accordance with national and international guidelines. VMAT plans were generated on different CBCT image sets of the phantoms. Results: Coefficient of variation in the X-ray output consistency was 0.0012. Slice thickness measured was within the tolerance. Hypersight CBCT proved its equality with CT in low contrast and high contrast resolution, uniformity and noise. HU accuracy and constancy closely matched the expected values in iterative CBCT (iCBCT) Accuros calculations. Target dosimetry between CT and iCBCT Accuros calculations were within 1% in Catphan and gamma analysis demonstrated excellent agreement. Conclusions: Overall, dosimetric accuracy and image quality confirm the superiority of this system for image-guided radiotherapy. Phantom results support ART workflows without intermediate steps; however, further clinical studies across treatment sites and improved scatter correction are required.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.